Saluda Medical Receives U.S. FDA Approval for New CAP24™ Surgical Paddle Lead

BLOOMINGTON, Minn., June 30, 2026 /PRNewswire/ -- Saluda Medical, Inc. (ASX: SLD, "Saluda" or the "Company"), a commercial-stage medical device company focused on developing treatments for chronic neurological conditions using its novel closed-loop neuromodulation platform, today...